About us

The Francis Crick Institute is Europe’s largest biomedical research institute under one roof. Our world-class scientists and staff collaborate on vital research to help prevent, diagnose and treat illnesses such as cancer, heart disease, infectious diseases and neurodegenerative conditions. 

The Crick is a place for collaboration, innovation and exploration across many disciplines. A space where the brightest minds can pursue big and bold ideas and discover answers to crucial scientific questions. We support them in a dynamic environment which fosters excellence with state-of-the-art infrastructure, cutting-edge facilities, and a creative and curious culture. We’ve removed traditional boundaries of departments, divisions and disciplines and instead have an open approach that supports every researcher. This gives us the freedom to take risks and carry out high-quality, pioneering research. Creating a space for discovery without boundaries helps us to turn our science into benefits for human health and the economy. 

About the role

The Crick Innovation and Business team has been created to establish an expanded translational and commercial offering from the Crick. There are four core functions: Translation & Entrepreneurship, Commercial Portfolio, Business Development and Business Operations.

The Business Development team is responsible for driving the development and execution of the Crick’s translation and commercial activity. This involves identifying partners for different translational and commercial opportunities, negotiating and concluding optimal deals and post-signature management to ensure delivery of such agreements. 

We are seeking a Strategic Business Development Lead (known internally as Senior Business Manager) with demonstrated expertise in innovation, commercialisation, intellectual property (IP), and due diligence to join this team.

Working closely with the Head of Business Development and the Business Development team, you will ensure appropriate identification, negotiation, conclusion and post-signature management of deals that further the Crick strategy, while protecting the charitable objectives.